Who Owns GE Diagnostics?
GE Diagnostics, formally the Pharmaceutical Diagnostics segment of GE HealthCare Technologies, Inc., is a business brand of a publicly traded company listed on Nasdaq under the ticker GEHC. The segment manufactures contrast agents and molecular imaging tracers used in CT, MRI, ultrasound, and PET scans. The parent reported approximately $20.1 billion in FY2025 revenue.
Parent Company
Founded
2023
Status
Publicly Traded
Headquarters
GlobalOfficial Website
Who Owns GE Diagnostics?
- Parent Company: GE HealthCare Technologies Inc.
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: Nasdaq: GEHC
| Brand | Parent Company | Ownership Type |
|---|---|---|
| GE Diagnostics | GE HealthCare Technologies Inc. | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
GE Diagnostics on AmazonAdvertisement
History of GE Diagnostics
- Founded: 2023
- Founders: GE HealthCare Technologies (corporate segment)
The contrast agent business traces to Nycomed, the Norwegian pharmaceutical company whose contrast media operations GE acquired through a series of purchases culminating in full ownership in the late 1990s and early 2000s. Omnipaque, Nycomed's flagship iodinated contrast agent, became the world's most widely used X-ray and CT contrast medium and the foundation of the diagnostics franchise.
GE expanded the business into MRI contrast with Clariscan and into molecular imaging tracers for PET scans, including Vizamyl for amyloid detection and Cerianna for breast cancer imaging. When GE spun off GE HealthCare in January 2023, Pharmaceutical Diagnostics became one of its four reportable segments. The newest product, Flyrcado, a PET myocardial perfusion agent approved by the FDA in September 2024, expanded the franchise into cardiology.
About GE HealthCare Technologies Inc.
What does GE HealthCare do?
GE HealthCare Technologies Inc. develops, manufactures, and sells medical imaging, diagnostics, and healthcare IT solutions. The company operates through four segments: Imaging (MRI, CT, X-ray), Ultrasound, Patient Care Solutions (patient monitoring, healthcare IT), and Pharmaceutical Diagnostics (contrast agents, radiopharmaceuticals). GE HealthCare serves customers in over 160 countries.
Is GE HealthCare publicly traded?
Yes, GE HealthCare Technologies Inc. is publicly traded on the Nasdaq stock exchange under ticker GEHC. The company was spun off from General Electric on January 4, 2023, and has been independently traded since. General Electric does not retain a significant stake.
Advertisement
Who is the CEO of GE HealthCare?
Peter Arduini serves as President and CEO of GE HealthCare. He was appointed to lead GE's healthcare division in 2022 ahead of the January 2023 spinoff and has continued as CEO of the independent company.
What is GE HealthCare's annual revenue?
GE HealthCare reported revenue of $20.1 billion for fiscal year 2025, up from $19.6 billion in 2024. Net income for 2025 was $2.0 billion. The company's growth was driven by strong demand for medical imaging equipment, AI-enabled imaging solutions, and pharmaceutical diagnostics products.
How was GE HealthCare created?
GE HealthCare was created through the spinoff of General Electric's healthcare division on January 4, 2023. The spinoff was part of GE's broader restructuring, which also created GE Vernova (April 2024) and GE Aerospace as independent companies.
What acquisitions has GE HealthCare made recently?
In 2025, GE HealthCare acquired Impact Medical's NMPA-approved AI software for CT imaging analysis, strengthening its position in the Chinese healthcare AI market. The company has also invested in AI-enabled imaging products and digital health platforms.
Advertisement
Where is GE HealthCare headquartered?
GE HealthCare is headquartered in Chicago, Illinois, USA. The company has manufacturing facilities in the United States, United Kingdom, France, China, and India, and serves customers in over 160 countries.
Who owns GE HealthCare?
GE HealthCare is a publicly traded company with a dispersed shareholder base. Institutional investors hold the majority of shares, with no single controlling shareholder. General Electric does not retain a significant stake following the spinoff.
- Founded: 2023
- Headquarters: Chicago, Illinois, USA
- Company Type: Publicly Traded
- Stock: Nasdaq: GEHC
- Revenue: $20.1 billion (FY2025)
- Employees: approximately 51,000
Where Is GE Diagnostics Made / Based?
- Headquarters: Chicago, Illinois, USA
GE Diagnostics Categories & Tags
Brands Owned by GE HealthCare Technologies Inc.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Healthcare PharmaceuticalsGE Imaging
Owned by GE HealthCare Technologies Inc.
Medical imaging equipment brand of GE HealthCare, covering MRI, CT, X-ray, and molecular imaging systems used in hospitals and diagnostic centers worldwide.
medical-devicesimagingmri
Advertisement
GE Diagnostics Ownership: Pros & Cons
Advantages
- +High-margin consumables business paired with parent's scanner installed base
- +Omnipaque and Clariscan are established global standards in contrast media
- +Regulatory moat: pharmaceutical approval creates high barriers to entry
- +Flyrcado extends the franchise into cardiology, a major growth indication
- +Recurring per-scan demand makes revenue predictable and repeatable
Considerations
- -Contrast media faces periodic safety scrutiny over gadolinium retention
- -Competitors Bayer and Bracco hold strong positions in iodinated agents
- -Supply concentration in few manufacturing sites creates production risk
- -Reimbursement changes for imaging directly pressure volume
- -Generic and biosimilar pressure builds as older agents lose exclusivity
Frequently Asked Questions About GE Diagnostics
Advertisement
Sources & Further Reading
Competitors to GE Diagnostics
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Siemens | Germany | 2018 | Premium | Global | All-ages | |
| Amgen | USA | 1980 | Market leader | Global | All-ages | |
| Amgen | USA (parent) | 2014 | Market leader | Global | All-ages | |
| Pacira Biosciences | USA | 2006 | Premium | United states | All Genders | |
| Amgen | USA (parent) | 2010 | Market leader | Global | All-ages | |
| Teva | Israel | 1901 | Leader | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsSiemens Healthineers
Owned by Siemens AG
German medical technology and healthcare equipment company providing diagnostic imaging and laboratory diagnostics, owned by Siemens AG.
medical-technologyhealthcarediagnostics
Healthcare PharmaceuticalsAmgen
Owned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
biotechnologypharmaceuticalsbiologics
Healthcare PharmaceuticalsOtezla
Owned by Amgen Inc.
Oral medication for psoriasis and psoriatic arthritis owned by Amgen Inc., the leading non-injectable treatment in its class.
pharmaceuticalspsoriasispsoriatic-arthritis
Healthcare PharmaceuticalsPacira
Owned by Pacira BioSciences, Inc.
Pharmaceutical brand behind non-opioid pain therapies EXPAREL and ZILRETTA, owned by Pacira BioSciences and being acquired by Viatris for $1.65 billion.
pharmaceuticalspain-managementnon-opioid
Healthcare PharmaceuticalsProlia
Owned by Amgen Inc.
Biologic osteoporosis medication owned by Amgen Inc., the leading injectable treatment for bone density loss.
pharmaceuticalsbiologicsosteoporosis
Healthcare PharmaceuticalsTeva Pharmaceuticals
Owned by Teva Pharmaceutical Industries
Israeli multinational pharmaceutical company and the world's largest generic drug manufacturer, publicly traded on NYSE under ticker TEVA, headquartered in Tel Aviv, Israel.
generic-drugspharmaceuticalsspecialty-medicines
Competitive Analysis
Market Positioning: GE Diagnostics competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to GE Diagnostics
Looking for brands with different ownership structures? These similar brands are not owned by GE HealthCare Technologies Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike GE Diagnostics which is under a publicly traded parent company.
Healthcare PharmaceuticalsTylenol
Owned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
pain-reliefmedicationpharmaceutical
Privately Owned
Tylenol is privately owned, unlike GE Diagnostics which is under a publicly traded parent company.
Healthcare PharmaceuticalsWalgreens
Owned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
pharmacydrugstoreretail-pharmacy
Privately Owned
Walgreens is privately owned, unlike GE Diagnostics which is under a publicly traded parent company.
Healthcare PharmaceuticalsZocdoc
Owned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
healthcareappointment-bookingdigital-health
Privately Owned
Zocdoc is privately owned, unlike GE Diagnostics which is under a publicly traded parent company.
Healthcare PharmaceuticalsAmgen
Owned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
biotechnologypharmaceuticalsbiologics
Publicly Traded
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsBenadryl
Owned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
antihistamineallergy-reliefcold-medicine
Privately Owned
Benadryl is privately owned, unlike GE Diagnostics which is under a publicly traded parent company.
GE HealthCare Technologies Inc. Stock Information
Advertisement
Jobs at GE HealthCare Technologies Inc.
Latest News About GE Diagnostics
Advertisement
Related Articles About GE Diagnostics
View more articles
Brand Comparisons
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.
Who Brands StaffMar 16, 2026
PharmaceuticalPfizerJohnson And Johnson
Brand Ownership
15 Pharmacy Brands and Their Corporate Parents
CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.
Who Brands StaffFeb 26, 2026
Pharmacy BrandsBrand OwnershipCvs
Brand Ownership
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.
Who Brands StaffFeb 5, 2026
VitaminsSupplementsBrand Ownership
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription